Several possible studies
Story checked
Stereo-seq now available in madrid via MGI tech partnership (opens in a new tab)
news-medical.net · 2026-11-04
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Stereo-seq now available in madrid via MGI tech partnership
news-medical.net · 2026-11-04
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 4Not checkedMGI Tech announced that the Genomics Unit at Parque Científico de Madrid has become the first STOmics Certified Service Provider in Madrid and the second at the national level in Spain.View evidenceHide evidence
As statedfirst in Madrid; second in Spain
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 4Not checkedThe collaboration brings Stereo-seq spatial transcriptomics capabilities to the Spanish R&D ecosystem, giving researchers, hospitals, and deep-tech companies access to unbiased, whole-transcriptome spatial analysis at true cellular and subcellular resolution.View evidenceHide evidence
As statedtrue cellular and subcellular resolution (500 nm)
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 4Not checkedMGI says the platform maps gene expression while preserving tissue context and is expected to accelerate advances in precision oncology, neuroscience, embryology, and plant biology.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 4Not checkedThe service will be delivered through an end-to-end collaboration with the Histology and Microscopy Services of the National Center for Biotechnology (CNB-CSIC), spanning tissue processing, imaging, sequencing, and bioinformatic analysis.View evidenceHide evidence
As statedend-to-end workflow
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Crossref, Europe PMC · 15 candidate papers
Spatial Transcriptomics for Dissecting Cellular and Molecular Heterogeneity in the Aging and Diseased Brain.
International Journal of Molecular Sciences · 2026 · PubMed
ELLA: Modeling Subcellular Spatial Variation of Gene Expression within Cells in High-Resolution Spatial Transcriptomics
2024 · Crossref
Decoding cardiac homeostasis and injury: the evolving landscape of spatial transcriptomics.
2026 · Europe PMC
Application of spatial transcriptomics across organoids for a high-resolution, spatial whole-transcriptome benchmarking dataset.
iScience · 2026 · PubMed
Seq-Scope: Submicrometer-resolution spatial transcriptomics for single cell and subcellular studies
2021 · Crossref